Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Ipca Laboratories

Ipca Laboratories Share Price

Ipca Laboratories (INR)1655.65-47.6   (-2.8%)

Exchange ScripsBSE524494NSEIPCALABISININE571A01038

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Ipca Laboratories Performance

Market performance
Open price1692
High1702.4
Volumes776695
Prev Close1655.65
Low1638.55
Closing date2024-10-16
Historical performance
1 Year High1708.65
3 Year High1708.65
5 Year High1708.65
1 Year Low933.10
3 Year Low669.80
5 Year Low443.42

Ipca Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
43210
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
78.95
Dividend Yield
Dividend Yield
0.23 %

Ipca Laboratories Investment Returns

1 Year
77.6%
3 Years
40.6%
5 Years
286%
10 Years
376.8%

Ipca Laboratories Technicals

IndicatorsValueSignal
5-DMA1657.24Bearish
10-DMA1588.49Bullish
20-DMA1530.11Bullish
50-DMA1450.27Bullish
100-DMA1326.76Bullish
200-DMA1270.31Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1616161616
Foreign Investors---------------
Domestic Investors1616161616
Public Investors8473781149827939591499873
Government---------------

Ipca Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1844151812171292
Operating Profit14484105501379316104
Interest1408482112123
Depreciation3572261623242092
Profit Before Tax842774531135713890
Consolidated Net Profit54734713884111400
Adjusted EPS22193545

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital254254254254
Total Reserves63052581665439546763
Minority Interest13948733769145
Total Non-Current Liabilities10144901761391897
Total Liabilities110970862297621560664
Capital Work in Progress3236122229391837
Total Assets110970862297621560664

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities94478058856110901
Cash Flow from Investing Activities-12918-7250-8550-5207
Cash Flow from Financing Activitie-552550724268-3058
Net Cash Inflow / Outflow-8997588042782636
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 78.95.
  • 3Y Stock Price CAGR of the stock is 12.1.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹14484 Million.
  • The company generated revenue of ₹76624 Million in the previous financial year.

Ipca Laboratories

1655.65-47.6   (-2.8%)

Investment Amount: ₹ 97315
Current Value: ₹ 165565
Performence: 70.1%
P/L: ₹ 68250
Top Gainers
SymbolChange%
PREMIERPOL332.18(20%)
VAISHALI21.97(20%)
ANGELONE3236(18%)
AJMERA830.7(16%)
MOTILALOFS962.05(12%)
Top Losers
SymbolChange%
HAVISHA2.64(-8%)
SOMATEX45.58(-7%)
SHANTI17.37(-7%)
WEL1491.9(-6%)
ORIENTLTD114.7(-6%)
DBCORP333.35(-6%)
DELTAMAGNT98.78(-6%)
SINDHUTRAD25.12(-6%)
Similar stocks

Neuland Laboratories

▲ 25

16250.7

September 16 - October 16

RPG Life Sciences

▲ 24.2

2818.8

September 16 - October 16

Vaishali Pharma

▲ 20.2

21.97

September 16 - October 16

Medicamen Biotech

▲ 17.4

531.4

September 16 - October 16

Strides Pharma Scien

▲ 15.6

1630.95

September 16 - October 16

Unichem Lab

▲ 13.9

727.1

September 16 - October 16

Astrazeneca Pharma I

▲ 12

7649.75

September 16 - October 16

Jagsonpal Pharma

▲ 11.4

449.4

September 16 - October 16

Announcing Stock of the Month!

Stock of the Month
Stock of the Month